No matter how cynical the overall market is Hims & Hers Health Inc (HIMS) performance over the last week is recorded 0.16%

Hims & Hers Health Inc (NYSE: HIMS) on Monday, soared 0.94% from the previous trading day, before settling in for the closing price of $56.33. Within the past 52 weeks, HIMS’s price has moved between $13.47 and $72.98.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

The company achieved an average annual earnings per share of 24.89%. With a float of $200.63 million, this company’s outstanding shares have now reached $215.21 million.

Let’s look at the performance matrix of the company that is accounted for 1637 employees. In terms of profitability, gross margin is 77.04%, operating margin of 6.16%, and the pretax margin is 6.71%.

Hims & Hers Health Inc (HIMS) Insider Updates

Observing investor behavior towards Household & Personal Products industry stocks is more important than anything else. The insider ownership of Hims & Hers Health Inc is 10.37%, while institutional ownership is 70.31%. The most recent insider transaction that took place on Jun 06 ’25, was worth 285,600. In this transaction Chief Commercial Officer of this company sold 5,100 shares at a rate of $56.00, taking the stock ownership to the 256,580 shares. Before that another transaction happened on Jun 06 ’25, when Company’s Officer proposed sale 5,100 for $56.00, making the entire transaction worth $285,600.

Hims & Hers Health Inc (HIMS) Performance Highlights and Predictions

Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.26 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around 24.89% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 34.57% during the next five years compared to 17.22% growth over the previous five years of trading.

Hims & Hers Health Inc (NYSE: HIMS) Trading Performance Indicators

Hims & Hers Health Inc (HIMS) is currently performing well based on its current performance indicators. A quick ratio of 1.32 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 7.13. Likewise, its price to free cash flow for the trailing twelve months is 54.10.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.69, a number that is poised to hit 0.15 in the next quarter and is forecasted to reach 0.95 in one year’s time.

Technical Analysis of Hims & Hers Health Inc (HIMS)

Hims & Hers Health Inc (NYSE: HIMS) saw its 5-day average volume 56.3 million, a positive change from its year-to-date volume of 31.58 million. As of the previous 9 days, the stock’s Stochastic %D was 24.50%. Additionally, its Average True Range was 4.90.

During the past 100 days, Hims & Hers Health Inc’s (HIMS) raw stochastic average was set at 67.11%, which indicates a significant increase from 35.00% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 64.14% in the past 14 days, which was lower than the 125.71% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $42.39, while its 200-day Moving Average is $31.60.

News Daemon
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.